For patients who continue to experience chronic spinal pain after physical therapy, injections, or surgery, regenerative options such as biologic disc repair may offer a path worth evaluating. Candidacy depends on individual anatomy, diagnosis, and prior treatment history — outcomes vary by case and are not guaranteed for any patient.

Why Conventional Treatments Often Fall Short

Many patients with chronic disc-related pain move through a standard sequence: physical therapy, anti-inflammatory medications, epidural steroid injections, and eventually surgical intervention. For some, each step provides meaningful relief. For others, pain persists or returns — sometimes within months of a procedure that initially seemed successful.

This pattern has a recognized name in spine medicine. Failed back surgery syndrome (FBSS) is estimated to affect a substantial portion of patients who undergo spinal surgery, though published estimates vary and outcomes depend heavily on the individual case. When surgery addresses bone or nerve compression but leaves underlying disc pathology untreated, the structural source of pain may remain active regardless of what was removed or fused.

Physical therapy and injections carry their own limitations in this context. Rehabilitation can strengthen supporting musculature and improve function, but it does not repair disc tissue. Corticosteroid injections reduce inflammation and may provide temporary relief, but repeated use carries risk and does not address annular damage. When conventional care cycles produce diminishing returns, it is worth asking whether the root structural cause has been identified and addressed.

The Role of Annular Tears in Chronic Disc Pain

The intervertebral disc is composed of a gel-like inner nucleus surrounded by a tough outer wall called the annulus fibrosus. When the annulus develops tears — through injury, degeneration, or accumulated stress — the disc loses its ability to contain internal pressure. This can lead to persistent inflammation, nerve irritation, and pain that does not resolve with rest or conservative care.

Annular tears are frequently implicated in chronic low back pain but are not always identified through standard imaging protocols. MRI may miss smaller or partial-thickness tears, particularly when imaging is not specifically sequenced to evaluate the annulus. Patients who have undergone multiple treatments without lasting relief may benefit from a more targeted diagnostic evaluation that accounts for this possibility.

For a deeper look at how annular pathology contributes to ongoing pain, see our resource on how annular tears cause chronic low back pain.

A Different Approach: Biologic Disc Repair

Biologic disc repair — specifically intra-annular fibrin injection — takes a fundamentally different approach from conventional surgery. Rather than removing disc tissue, decompressing nerves, or fusing vertebral segments, this technique introduces a biologic agent directly into the damaged annulus with the goal of supporting the disc’s natural healing environment.

Fibrin is a protein the body uses in its own clotting and tissue-repair processes. When delivered precisely into annular tears, it may help stabilize the disc structure and reduce the inflammatory signals associated with annular damage. The procedure is performed using advanced imaging guidance to target affected areas with precision.

This approach is not appropriate for every spine condition, and candidates do not respond in the same way. Our clinical team evaluates each patient individually to determine whether the disc architecture and overall clinical picture support this type of intervention. Recovery timelines and outcomes vary by case.

Expert Take

Biologic disc repair is not a universal solution, and we do not present it as one. What distinguishes this approach is that it attempts to address annular pathology directly rather than working around it. For patients who have exhausted conventional options and still have structurally repairable disc tissue, a targeted evaluation is a reasonable next step — not a guarantee of relief, but a more precise look at what may still be treatable.

For patients who have experienced spinal surgery without lasting improvement, understanding whether a biologic approach might be applicable is worth discussing with a qualified specialist. Our resource on failed back surgery syndrome and regenerative options covers this in more detail.

Additional background on the fibrin disc treatment approach is available in our clinical overview of fibrin disc treatment for annular tears.

Who May Be a Candidate

Candidacy for intra-annular fibrin injection is determined through a structured evaluation process, not a checklist. That said, certain clinical profiles appear frequently among patients our team considers for this approach:

• Persistent axial or radicular pain that has not responded adequately to at least six months of conservative care
• Prior surgical intervention that provided incomplete or temporary relief
• Imaging or diagnostic findings consistent with annular pathology
• Disc structure that has retained enough integrity to be a viable target for biologic repair
• No active infection, malignancy, or other systemic contraindication

Patients who have undergone fusion at one level may still have adjacent disc pathology that warrants evaluation. Prior surgery does not automatically disqualify a patient, but it does shape how the evaluation is conducted and what outcomes are realistic to anticipate.

Age, overall health status, pain duration, and the specific distribution of symptoms all factor into candidacy. Our clinical team does not apply a one-size-fits-all threshold — each case is reviewed based on its own findings.

What the Evaluation Process Involves

An initial evaluation at our clinic is designed to answer one question: is there a structurally addressable source of this patient’s pain, and if so, is biologic disc repair a reasonable intervention to consider?

The process typically involves:

• Comprehensive history review: Prior diagnoses, imaging records, treatment history, and response to previous interventions are collected and reviewed before the first visit when possible.
• Physical and neurological examination: Our clinical team assesses pain distribution, movement patterns, neurological signs, and functional limitations.
• Advanced imaging review: Existing MRI and other imaging are evaluated. In some cases, additional or updated imaging may be recommended to better characterize disc pathology.
• Diagnostic discussion: Patients receive a clear explanation of what the findings suggest, what options may apply to their case, and what realistic expectations look like — including scenarios where biologic repair may not be the appropriate next step.

We do not recommend fibrin disc treatment unless the clinical picture supports it. In cases where it does not, our team works with patients to identify what alternative directions may be appropriate.

Taking the Next Step

Chronic spinal pain that has persisted through multiple treatments is not evidence that nothing can be done — but it does suggest that the underlying cause may not yet have been fully addressed. For some patients, intra-annular fibrin injection represents a viable next step. For others, a thorough evaluation will clarify why prior treatments fell short and what direction makes most sense going forward.

The evaluation itself carries value independent of whether fibrin disc treatment turns out to be appropriate. Understanding the structural source of persistent pain — with precision — is the foundation of any treatment decision that is likely to hold.

If you are navigating ongoing spinal pain after prior procedures and want to understand whether our clinical team can offer a clearer picture of what may still be treatable, we invite you to reach out and begin with a consultation.